Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Now Feluda to detect Covid cases : Tata Group to launch India's CRISPR Covid Test
FELUDA is actually an acronym - FNACS9 Editor Linked Uniform Detection Assay (FELUDA) – for an indigenous test for rapid diagnosis of Covid-19.

India’s first COVID-19 detecting paper strip ‘Feluda’ delivers results within minutes! One of the most pertinent questions going on in everyone’s head is if they are infected with Coronavirus but have no symptoms? In a matter of minutes, courtesy writer and film-maker Satyajit Ray’s popular fictional detective, ‘Feluda,’ could now clear all your doubts. The ‘Feluda’ is a paper-based test strip that detects the latest coronavirus in an hour, and can now be the solution to the urgent need for rapid testing in India, a LiveMint report indicates.

A team led by two scientists of Bengali descent, Dr. Souvik Maiti and Dr. Debojyoti Chakraborty, at the Institute of Genomics and Integrative Biology (CSIR-IGIB) of the Council of Science & Industrial Research in New Delhi, have come up with a simple strip-test to tell you if you have COVID-19 in minutes, a New18 report has stated. The study uses the state-of-the-art gene-editing tool-Crispr-Cas9 to target and identifies genomic sequences of the novel coronavirus in suspected individual samples.

The kit is similar to a compact paper-strip test used to confirm pregnancy and is much less complex and needs no specific professional expertise to perform. The team led by Dr Souvik Maiti and Dr Debjyoti Chakraborty is currently testing the package in a patient population for its accuracy and responsiveness and hopes to obtain approval within a week from an Indian Medical Research Council (ICMR) regulatory body.

Unlike the real-time PCR test currently being used for Covid-19 diagnosis in India, which costs about 4500, the paper-strip test costs less than 500. It also does not rely on expensive real-time PCR machines for RNA isolation, DNA conversion, and amplification which are already in limited supply, the News18 report indicated.

Although this method has been tested by scientists in other countries including Stanford University and the Massachusetts Institute of Technology (MIT), it is the first such indigenous test kit to be developed in India based on CRISPR technology.

This testing method can be a boon for India where lockdown is about to end and people will have to come back to work. The ability to know if they have Coronavirus infection or not will help firms and employees in decision making over the resumption of coming to the office for work.

Tags : #FeludaCovidTest #FNACS9EditorLinkedUniformDetectionAssay #StanfordUniversity #MIT #MadeInIndiaCovidTest #LatestCovidNewsUpdateSep21 #LatestCovidTestingNewsUpdateSep21

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026
Dhiya Fertility and Maternity Center Performs Tamil Nadu’s First Robot-Assisted Fertility Procedure; 37-Year-Old Woman Delivers Healthy Baby GirlOctober 01, 2026
Habuild’s “Are You Still Awake?” Campaign Encourages India to Switch Off, Sleep on Time and Not Take Everything to Heart October 01, 2026
CoinSwitch Turns Profitable in FY26 as Revenue Surges 150% to ₹324 CrOctober 01, 2026
Mega CPR Training: Baby Memorial Hospital Vadakara enters Asia and India Book of RecordsOctober 01, 2026
Supertails vaccinates 300 dogs and cats against rabies across Bengaluru in a three-day World Rabies Day drive October 01, 2026
Why Continuity of Care Matters When Patients Move Between Health FacilitiesOctober 01, 2026
Building Stronger Referral Pathways Between Primary Care and Specialist ServicesOctober 01, 2026